mHealth HBCR could improve access and health outcomes in patients who are unable to attend CBCR. Further research is needed to build a robust evidence base on the clinical effectiveness and cost-effectiveness of mHealth HBCR, particularly in comparison with CBCR, to inform clinical practice and policy.
MACS associated with unilateral adrenal incidentalomas is responsible for secondary hypertension that can be safely improved by minimally-invasive adrenalectomy.
The detection of incidental adrenal nodules is increasing as a direct result of widespread abdominal imaging, and mild autonomous cortisol secretion (MACS) is the most…
The increasing use of immunotherapeutic approaches, cellular therapies, and targeted agents is rapidly and profoundly changing the treatment paradigms of haematological malignancies. These novel therapies…
Stay up to date in your field with our Oncology Collection. Explore all related content published across The Lancet Group. The Lancet Child & Adolescent Health…
AbstractBackground and Aims. Standardized definitions for outcome measures in randomized clinical trials and observational studies are essential for robust
An update to the original 2016 Commission, this second iteration of The Lancet Commission on adolescent health and wellbeing presents crucial data on the challenges…
Neurological disorders are the leading cause of disease burden, affecting more than 3 billion people worldwide, and the second leading cause of death.1 The burden…
Our results show that the outcome in individuals with gestational diabetes is not improved by the use of rtCGM. However, individuals expressed a higher preference…
Gestational diabetes affects between 7·1–27·6% of pregnancies, depending on the global region.1 Management effectively reduces complications in both early2 and late3 pregnancy and includes education,…
Current interventions bring about improvements in medication adherence, but such improvements are not sustained over the long-term. For real world and practice implications, interventions must…
